The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herrick, C. A.
Right arrow Articles by Bottomly, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrick, C. A.
Right arrow Articles by Bottomly, K.
The Journal of Immunology, 2003, 170: 2488-2495.
Copyright © 2003 by The American Association of Immunologists

IL-13 Is Necessary, Not Simply Sufficient, for Epicutaneously Induced Th2 Responses to Soluble Protein Antigen1

Christina A. Herrick2,*,{dagger}, Lan Xu{dagger}, Andrew N. J. McKenzie{ddagger}, Robert E. Tigelaar*,{dagger} and Kim Bottomly*,{dagger}

* Department of Dermatology and {dagger} Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520; and {ddagger} Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom

Th2 responses are clearly involved in the pathogenesis of atopic disease. Thus, understanding the factors responsible for Th2 sensitization at sites of allergen exposure, such as airway and skin, is crucial for directing therapeutic or preventive strategies. Contrary to other models of Th2 sensitization to proteins, we have reported that Th2 responses induced by epicutaneous exposure to OVA are IL-4 independent. Combined deficiency of both IL-4 and IL-13 signaling did prevent Th2 generation, suggesting that IL-13 was mediating these IL-4-independent responses. It was not clear, however, whether IL-13 was simply replacing the need for IL-4 in genetically deficient mice or if IL-13 played a unique role. In the present study, we show that Th2 responses induced by epicutaneous OVA exposure (including lung inflammatory responses after inhaled Ag challenge, OVA-specific IgG1, and draining lymph node IL-5 production) are impaired in IL-13-deficient (IL-13-/-) mice compared with wild type. In contrast, i.p. sensitization of IL-13-/- mice resulted in responses equivalent to wild type. Generation of contact hypersensitivity to dinitrofluorobenzene, which involves Th1 and CD8+ effector cells, was also intact in IL-13-/- mice. Taken together, the data indicate that IL-13 is the major inducer of Th2 generation in the cutaneous microenvironment, being required independently of IL-4. This fact, in combination with the known abundance of IL-13 in atopic dermatitis skin lesions, emphasizes the potentially important role of the skin as a site for Th2 sensitization to environmental allergens, particularly in atopic individuals.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
Y. Morioka, K. Yamasaki, D. Leung, and R. L. Gallo
Cathelicidin Antimicrobial Peptides Inhibit Hyaluronan-Induced Cytokine Release and Modulate Chronic Allergic Dermatitis
J. Immunol., September 15, 2008; 181(6): 3915 - 3922.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
P. L. Martin, D. Fisher, W. Glass, K. O'Neil, A. Das, E. C. Martin, and L. Li
Preclinical Safety and Pharmacology of an Anti-Human Interleukin-13 Monoclonal Antibody in Normal Macaques and in Macaques with Allergic Asthma
International Journal of Toxicology, September 1, 2008; 27(5): 351 - 358.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S.-Y. Nam, Y.-H. Kim, J.-S. Do, Y.-H. Choi, H.-J. Seo, H.-K. Yi, P.-H. Hwang, C.-H. Song, H.-K. Lee, J.-S. Kim, et al.
CD30 supports lung inflammation
Int. Immunol., February 1, 2008; 20(2): 177 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Muller, W. Stenzel, G. Kohler, C. Werner, T. Polte, G. Hansen, N. Schutze, R. K. Straubinger, M. Blessing, A. N. J. McKenzie, et al.
IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans
J. Immunol., October 15, 2007; 179(8): 5367 - 5377.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
I. Kalomenidis, Y. Guo, R. S. Peebles, K. B. Lane, S. Papiris, J. Elias, and R. W. Light
Pneumothorax-Associated Pleural Eosinophilia in Mice Is Interleukin-5 but Not Interleukin-13 Dependent
Chest, October 1, 2005; 128(4): 2978 - 2983.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Padilla, E. Daley, A. Chow, K. Robinson, K. Parthasarathi, A. N. J. McKenzie, T. Tschernig, V. P. Kurup, D. D. Donaldson, and G. Grunig
IL-13 Regulates the Immune Response to Inhaled Antigens
J. Immunol., June 15, 2005; 174(12): 8097 - 8105.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Kouriba, C. Chevillard, J. H. Bream, L. Argiro, H. Dessein, V. Arnaud, L. Sangare, A. Dabo, A. H. Beavogui, C. Arama, et al.
Analysis of the 5q31-q33 Locus Shows an Association between IL13-1055C/T IL-13-591A/G Polymorphisms and Schistosoma haematobium Infections
J. Immunol., May 15, 2005; 174(10): 6274 - 6281.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
L. Aurelian
Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?
Clin. Vaccine Immunol., May 1, 2004; 11(3): 437 - 445.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.